University of Washington
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Washington sits in the top decile of US sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count).
University of Washington: 1,048 sponsored US clinical trials, 156 recruiting.
University of Washington sponsors 1,048 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 720 completed. 104 of these trials are in Phase 3-4 (later-stage) and 320 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 13 trials.
Top-decile sponsor footprint
University of Washington ranks in the top decile of sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
720 of 816 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,048 total, page 19 of 21
Resuscitation Outcomes Consortium (ROC) Prehospital Resuscitation Using an Impedance Valve
NCT00394706
Sweetened Beverages and Food Intake
NCT00475475
Nurse-led Case Management for Diabetes and Cardiovascular Disease Patients With Depression
NCT00468676
Promoting Infant Mental Health in Foster Care
NCT00339365
Marketing Workplace Chronic Disease Prevention
NCT00452816
Improving Clinician Communication Skills (ICCS)
NCT00687349
High-Risk HPV Infections in Women Aged 25 to 65
NCT00461877
Trial of Spirometry Fundamentals™ in the Primary Care Setting
NCT01152320
SPHERE Hypertension Baseline Data Study
NCT00444496
Automated Real-time Feedback on CPR Study
NCT00539539
Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer
NCT00498901
Mycoplasma Genitalium Antibiotic Susceptibility and Treatment (MEGA)
NCT00358462
Carotid Ultrasound Sub-Study of the Familial Atherosclerosis Study-observational Study
NCT00976014
Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer
NCT00466752
Development of a Methamphetamine Early Intervention
NCT01174654
Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT00425646
Oral Androgens in Man-4: (Short Title: Oral T-4)
NCT00399165
Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer
NCT00416715
Efficacy of Early Stage Alzheimer's Support Groups
NCT00391794
Flumazenil Reversal of Oral Triazolam
NCT00695630
Primary Care Obesity Prevention and Treatment
NCT00944164
Effects of Low and Moderate Fat Diets on Lipids, Inflammation and Vascular Reactivity in the Metabolic Syndrome
NCT00362908
Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2
NCT00362297
Immunomodulation Following Transfusion
NCT00810810
Diagnostic Accuracy of Multislice CT Angiography for Acute Chest Pain
NCT00855231
Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer
NCT00298155
A Phase II Randomized Trial of Fish Oil in Patients With Acute Lung Injury (ALI)
NCT00351533
Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer
NCT00410826
SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)
NCT00438568
Behavioral Sleep Intervention in Adult Family Homes
NCT00393627
Patient-Centered Collaborative Care for Preventing Post-Traumatic Stress Disorder After Traumatic Injury
NCT00270959
Primary Care Intervention Strategy for Anxiety Disorders
NCT00347269
Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus Osteomyelitis
NCT00324922
Real-Time Support for Exercise Persistence in COPD
NCT00373932
PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer
NCT00362973
Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery
NCT00407888
Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy
NCT00466960
Hypertonic Resuscitation Following Severe Traumatic Brain Injury (TBI)
NCT00316004
Hypertonic Resuscitation Following Traumatic Injury
NCT00316017
Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.
NCT00446459
Evaluating the Collaborative Management in Pediatrics (CMP) Training Program Among Pediatric Resident Doctors and Their Patients With Asthma or Obesity
NCT00510341
Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2
NCT00363012
Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection
NCT00305227
Computer Assisted Rx Education for HIV-Positives: CARE+
NCT00443378
Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer
NCT00331552
Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT00408460
Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas
NCT00276770
SMART: Somatotrophics, Memory, and Aging Research Trial
NCT00257712
Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer
NCT00343863
Subgroups of Fibromyalgia Syndrome (FMS): Symptoms, Beliefs, and Tailored Treatment
NCT00762125
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 127 |
| Phase 2 | 193 |
| Phase 3 | 39 |
| Phase 4 | 65 |
What is open in the University of Washington pipeline
156 recruiting of 1,048 indexed (15% open); 720 completed (69%).
Phase mix: 104 late (III/IV) vs 320 early (I/II) (early-phase heavy).
Top condition: Depression (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Washington: open-pipeline peers nationwide
Peers matched on 1,048 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Washington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,048 trials (± recruiting share)
- University of Wisconsin, Madison · 1,039 trials · 15% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
- University of Florida · 1,106 trials · 15% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Dompé Farmaceutici S.p.A · 15% recruiting · 27 trials
- Vanderbilt-Ingram Cancer Center · 15% recruiting · 189 trials
- Arizona State University · 15% recruiting · 187 trials
- Georgetown University · 15% recruiting · 227 trials
Related
What to do with this University of Washington page
1,048 registered trials is a research-attention snapshot, not an endorsement of University of Washington or any single study.
- 156 of University of Washington's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Washington studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Washington pipeline card: 1,048 registered trials from official public datasets.Report a data error.